The primary concern is the potential for deterioration in blood glucose control, which can lead to hyperglycaemia
But the additive benefit of combining them remains theoretical
After a median follow-up of 104 weeks, treatment with tirzepatide was associated with a significant reduction in the risk of adjudicated death from cardiovascular causes or a worsening heart failure event (hazard ratio (HR) = 0.62
Call me if: You're vomiting and can't keep water down You have severe pain at the injection site You see signs of infection (warmth, pus, spreading redness) You're having trouble breathing or showing signs of an allergic reaction You're so nauseous you can't eat for more than 24 hours You just feel really off, and something doesn't seem right Don't call me if: You have mild nausea (totally normal) You saw a drop of blood (also normal) You're tired on the first day (expected) You have a small bruise (happens sometimes) When in doubt, send a message through the patient portal or call
Beyond the Basics: Advanced Considerations for Researchers Mastering reconstitution is the first step
For supplier-focused information, Reta Supplier UK and Peptide Suppliers UK may also be useful